Cipla logo

Cipla share news, announcements and annual reports

NSE: CIPLABSE: 500087Pharmaceuticals & BiotechnologyLarge Cap

Cipla Limited · Face value ₹2 · Listed Jul 1983 on BSE, Feb 1995 on NSE
Last close ₹1,387.00up ₹8.10 (0.59%)BSE ₹1,382.00

Share price at the NSE close on 2 Nov 2026. Previous close ₹1,378.90.

2 Nov: open ₹1,383.00, high ₹1,391.00, low ₹1,364.60

52-week range of traded prices to 2 Nov 2026
₹1,165.70Low, 2 Apr 2026₹1,539.70High, 6 Jan 2026
Market cap
₹1,12,052 Cr99th largest listed
P/E
38.68
P/B
3.17
Dividend yield
0.94%
ROE
8.5%
ROCE
9.7%
Debt to equity
0.01
Volume, NSE
13,77,33662.2% delivered

Cipla board meetings

134 filed, newest first. Page 2 of 3.

  1. Aug 2020

  2. Jul 2020

  3. May 2020

  4. Feb 2020

  5. Jan 2020

  6. Nov 2019

  7. Oct 2019

  8. Aug 2019

  9. Jul 2019

  10. May 2019

  11. Apr 2019

  12. Jan 2019

  13. Oct 2018

  14. Aug 2018

  15. Jul 2018

  16. May 2018

  17. Apr 2018

  18. Feb 2018

  19. Jan 2018

  20. Nov 2017

  21. Oct 2017

  22. Aug 2017

  23. Jul 2017

  24. May 2017

  25. Jan 2017

  26. Dec 2016

  27. Nov 2016

  28. Aug 2016

  29. May 2016

  30. Feb 2016

  31. Oct 2015

  32. Aug 2015

  33. Jul 2015

  34. May 2015

  35. Feb 2015

    • 4 Feb · Board meeting

      Inter alia, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2014.

  36. Nov 2014

  37. Aug 2014

    • 6 Aug · Board meeting

      Inter alia, to consider and approve unaudited financial results for the quarter ended June 30, 2014. Further that in terms of Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading, the "trading window" for dealing in the securities of the company will remain closed from August 6, 2014 till completion of 24 hours after the unaudited financial results are made public.

  38. May 2014

  39. Mar 2014

    • 13 Mar · Board meeting

      Board of Directors of the Company at its meeting held on March 13, 2014, inter alia, has transacted the following items of business:- 1) Retirement of Mr. M. K. Hamied as Executive Vice-Chairman Mr. M. K. Hamied has expressed his desire to retire as Executive Vice-Chairman of the Company. The Board unanimously acknowledges the outstanding contribution of Mr. M. K. Hamied to the Company over the past 30 years, and in deference to his wishes, has accepted his proposal to retire as Executive Vice-Chairman effective March 31, 2014. Mr. M. K. Hamied however continues to be the Vice-Chairman of the Company in a non-executive role effective April 01, 2014. 2) Appointment of Mr. Rajesh Garg as Executive Director and Global Chief Financial Officer Mr. Rajesh Garg has been designated as "Executive Director and Global Chief Financial Officer" and appointed as an Additional Director and Whole-time Director of the Company with effect from April 01, 2014. Mr. Rajesh Garg joined the Company as its Global Chief Financial Officer on June 03, 2013.

  40. Feb 2014

    • 4 Feb · Board meeting

      Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2013 (Q3). Pursuant to the above and in terms of Company s Code of Internal Procedures and Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company will remain closed from 6:00 p.m. on February 04, 2014 till completion of 24 hours after the unaudited financial results are made public.

  41. Nov 2013

    • 1 Nov · Board meeting

      Inter-alia to consider Unaudited Financial Results for quarter and half year ended September 30, 2013.